Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis.
暂无分享,去创建一个
A David Paltiel | Erika G Martin | Bruce R Schackman | Rochelle P Walensky | R. Walensky | B. Schackman | A. Paltiel | E. Martin | Rochelle P. Walensky
[1] M. Niezen,et al. Role of budget impact in drug reimbursement decisions. , 2008, Journal of health politics, policy and law.
[2] Lisa M. Lee,et al. Estimation of HIV incidence in the United States. , 2008, JAMA.
[3] K. Freedberg,et al. Understanding delay to medical care for HIV infection: the long-term non-presenter , 2001, AIDS.
[4] R. Wolitski,et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials , 2006, AIDS.
[5] J. Holahan,et al. Rising Unemployment, Medicaid and the Uninsured , 2009 .
[6] Douglas K Owens,et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. , 2005, The New England journal of medicine.
[7] Milton C Weinstein,et al. Expanded screening for HIV in the United States--an analysis of cost-effectiveness. , 2005, The New England journal of medicine.
[8] J. Bartlett,et al. Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. , 2008, JAMA.
[9] B. Branson,et al. Comparing the Costs of HIV Screening Strategies and Technologies in Health-Care Settings , 2008, Public health reports.
[10] Phalguni Gupta,et al. Effect of Antiretroviral Therapy on HIV Shedding in Semen , 2000, Annals of Internal Medicine.
[11] T. Quinn,et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.
[12] N. Sikka,et al. Routine HIV Screening in the Emergency Department Using the New US Centers for Disease Control and Prevention Guidelines: Results From a High-Prevalence Area , 2007, Journal of acquired immune deficiency syndromes.
[13] M. Lyons,et al. Emergency department HIV testing and counseling: an ongoing experience in a low-prevalence area. , 2005, Annals of emergency medicine.
[14] B. Branson. Current HIV epidemiology and revised recommendations for HIV testing in health‐care settings , 2007, Journal of medical virology.
[15] R. Walensky,et al. Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. , 2005, American journal of public health.
[16] M. Weinstein,et al. Budget Impact of Medicaid Section 1115 Demonstrations for Early HIV Treatment , 2005, Health care financing review.
[17] M. Weinstein,et al. TREATMENT FOR PRIMARY HIV INFECTION: PROJECTING OUTCOMES OF IMMEDIATE, INTERRUPTED, OR DELAYED THERAPY , 2002, Journal of acquired immune deficiency syndromes.
[18] David R. Holtgrave,et al. Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. , 1996, Public health reports.
[19] David R. Holtgrave,et al. Cost comparison of three HIV counseling and testing technologies. , 2003, American journal of preventive medicine.
[20] M C Weinstein,et al. The cost-effectiveness of preventing AIDS-related opportunistic infections. , 1998, JAMA.
[21] Kenneth A. Freedberg,et al. A Monte Carlo Simulation of Advanced HIV Disease , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[22] R. Sesso,et al. Gaining efficiencies: resources and demand for dialysis around the globe. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[23] Milton C Weinstein,et al. The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States , 2006, Medical care.
[24] B. Branson,et al. Detecting Unsuspected HIV Infection With a Rapid Whole-Blood HIV Test in an Urban Emergency Department , 2007, Journal of acquired immune deficiency syndromes.
[25] David R. Holtgrave. Costs and Consequences of the US Centers for Disease Control and Prevention's Recommendations for Opt-Out HIV Testing , 2007, PLoS medicine.
[26] M C Weinstein,et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. , 2001, The New England journal of medicine.
[27] W. Cunningham,et al. Consistency of State Statutes With the Centers for Disease Control and Prevention HIV Testing Recommendations for Health Care Settings , 2009, Annals of Internal Medicine.
[28] W. McIsaac,et al. Effect of an Explicit Decision-Support Tool on Decisions to Prescribe Antibiotics for Sore Throat , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[29] Lauren M. Mercincavage,et al. Expanded HIV Screening in the United States: Effect on Clinical Outcomes, HIV Transmission, and Costs , 2006, Annals of Internal Medicine.
[30] Mark Nuijten,et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[31] Melissa Skanderson,et al. Development and Verification of a “Virtual” Cohort Using the National VA Health Information System , 2006, Medical care.
[32] S. Lyss,et al. Implementing an HIV and sexually transmitted disease screening program in an emergency department. , 2007, Annals of emergency medicine.
[33] Gary Marks,et al. Meta-Analysis of High-Risk Sexual Behavior in Persons Aware and Unaware They are Infected With HIV in the United States: Implications for HIV Prevention Programs , 2005, Journal of acquired immune deficiency syndromes.
[34] Richard D Moore,et al. Hospital and Outpatient Health Services Utilization Among HIV-Infected Adults in Care 2000–2002 , 2005, Medical care.
[35] M. Weinstein,et al. Preevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.